Navigation Links
PAREXEL International To Present At Robert Baird Healthcare Conference And Raymond James North American Equities Conference
Date:9/4/2013

BOSTON, Sept. 4, 2013 /PRNewswire/ -- PAREXEL International Corporation (NASDAQ: PRXL) announced today that it will be presenting at the Robert Baird Healthcare Conference on Tuesday, September 10, 2013, in New York.  Joseph von Rickenbach, Chairman and Chief Executive Officer, will be making a presentation on PAREXEL and discussing business developments at 2:20 p.m. ET.

PAREXEL will also be presenting at the Raymond James North American Equities Conference on Tuesday, September 10, 2013, in London.  James Winschel, Executive Vice President, will be making a presentation on PAREXEL and discussing business developments at 2:20 p.m. GBT.

A live webcast of the presentations will be available through the "Investors" section of PAREXEL's website at www.PAREXEL.com in the Upcoming Events portion of the main page, and a replay of the presentation will be available on the website until December 10, 2013.

About PAREXEL International

PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of knowledge-based contract research, consulting, and medical communications services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement. Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process. Headquartered near Boston, Massachusetts, PAREXEL operates in 77 locations in 51 countries around the world and has 14,700 employees.  For more information about PAREXEL International visit www.PAREXEL.com.

PAREXEL, Perceptive Informatics, LIQUENT, and HERON are registered trademarks of PAREXEL International Corporation or its affiliates.

Contact:
Jill Baker, Corporate Vice President, Investor Relations
PAREXEL International
Tel: +781-434-4118
Email: Jill.Baker@parexel.com


'/>"/>
SOURCE PAREXEL International Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. PAREXEL International Reports Fourth Quarter And Fiscal Year 2013 Results
2. Financial Results, Earnings Schedules, Quarterly Dividends, and Top Rankings - Research Report on Quest Diagnostics, PerkinElmer, PAREXEL, Covance, and ICON
3. PAREXEL Launches New Functional Services Unit
4. PAREXEL Invites Public To Listen To Live Webcast Of Its Investor Day June 26, 2013
5. PAREXEL International nombra a Ingo Bank como vicepresidente y responsable financiero
6. PAREXEL International Appoints Ingo Bank As Senior Vice President And Chief Financial Officer
7. PAREXEL International To Present At William Blair Growth Stock Conference And Goldman Sachs Healthcare Conference
8. PAREXEL International To Present At Jefferies Healthcare Conference
9. PAREXEL Honored with 2013 "Partnership Pioneers of the Year" Award
10. New PAREXEL Report Defines The Next Generation Of Strategic Partnerships Between CROs And Biopharmaceutical Industry
11. PAREXEL International Provides Update On Share Repurchase Program, Announces A New $50 Million Accelerated Share Repurchase Agreement And A New $50 Million 10b5-1 Trading Plan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2016)... 2016 According to a ... Market by Type (Stability, Raw Materials, Method Validation, ... (Pharmaceutical Companies, Medical Device Companies) - Global Forecast ... healthy growth during the last decade and is ... between 2016 and 2021 to reach USD 4.13 ...
(Date:5/30/2016)... Eye expert s ... seek an eye examination before leaving ...   Moorfields Eye Hospital Dubai, the first overseas branch ... , has identified premature babies as a special concern in the ... vulnerability to retinopathy of prematurity (ROP). ROP is a potentially blinding ...
(Date:5/27/2016)... TEL-AVIV, Israel , May 27, 2016 /PRNewswire/ ... KTOV), an innovative biopharmaceutical company focused on late-stage ... by Dexcel Pharma of pivotal batches ... Food and Drug Administration (FDA). This follows Kitov,s ... pivotal Phase III trial successfully met its primary ...
Breaking Medicine Technology:
(Date:5/31/2016)... ... 2016 , ... TeaZa® Energy, LLC announces the launch of a ... Tobacco Day . The new flavor—Tropical TeaZa? Energy—will be available to customers exclusively ... The new flavor is best described as a juicy, taste bud takeover. A ...
(Date:5/31/2016)... Aviv (PRWEB) , ... May 31, 2016 , ... ... the May 4, 2016 Cool Vendors in Security Infrastructure Protection report by Gartner1 ... and publishes a series of research reports evaluating these innovative vendors and their ...
(Date:5/31/2016)... ... May 31, 2016 , ... Advertising ... firm and statement solutions provider, for the tenth consecutive year as a Top ... of Advertising Age, and SourceLink ranked eighteenth in the “U.S. CRM/Direct Marketing Agency” ...
(Date:5/31/2016)... ... 31, 2016 , ... CURE Media Group , the ... added Cancer and Careers to its Advocacy Spotlight Partnership ... successful careers while fighting cancer. , As partners, both organizations will supply timely ...
(Date:5/30/2016)... Miami, FL (PRWEB) , ... May 30, 2016 , ... ... will means for their children and their efforts to keep their households lice free. ... schools across Hawaii are enacting new policies that keep kids in the classroom despite ...
Breaking Medicine News(10 mins):